menu search

ERYP / Why Is Erytech Pharma (ERYP) Stock Up 47% Today?

Why Is Erytech Pharma (ERYP) Stock Up 47% Today?
Erytech Pharma (NASDAQ: ERYP ) stock is on the rise Tuesday after the company provided investors with a business update for Q1! First up is the company's planned merger with Pherecydes. Read More
Posted: May 9 2023, 08:11
Author Name: InvestorPlace
Views: 103148

ERYP News  

Erytech Pharma SA (ERYP) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 13, 2023

Erytech Pharma SA (ERYP) Q1 2023 Earnings Call Transcript

Erytech Pharma SA (NASDAQ:ERYP ) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Gil Beyen - CEO Thibaut du Fayet - CEO, more_horizontal

Why Is Erytech Pharma (ERYP) Stock Up 47% Today?

By InvestorPlace
May 9, 2023

Why Is Erytech Pharma (ERYP) Stock Up 47% Today?

Erytech Pharma (NASDAQ: ERYP ) stock is on the rise Tuesday after the company provided investors with a business update for Q1! First up is the compan more_horizontal

Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%

By Zacks Investment Research
August 26, 2022

Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%

After evaluating the FDA's feedback, Erytech Pharma (ERYP) halts developing its lead candidate in leukemia. It is also looking for strategic partnersh more_horizontal

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 13, 2022

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2022 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (NASDAQ:ERYP ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Gil Beyen – Chief Executive Officer more_horizontal

Why Erytech Pharma Are Shares Moving Higher Today

By Benzinga
April 25, 2022

Why Erytech Pharma Are Shares Moving Higher Today

Erytech Pharma SA (NASDAQ: ERYP) has sold its US manufacturing facility to Catalent Inc (NYSE: CTLT) for $44.5 million. Catalent will acquire Eryt more_horizontal

Why Erytech Pharma Shares Are Rising Today

By Benzinga
April 7, 2022

Why Erytech Pharma Shares Are Rising Today

Erytech Pharma SA (NASDAQ: ERYP) says that the results from the NOPHO sponsored Phase 2 trial of eryaspase in acute lymphoblastic leukemia (ALL) pati more_horizontal

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 14, 2022

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: